Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Eye implant receives FDA approval for correcting mild myopia

April 13, 1999

PhotoVision in-licenses novel technology for development of AMD treatment

April 7, 1999

Xalatan approved in Japan for glaucoma and ocular hypertension

March 16, 1999

Licensing opportunity from the NIH: antiinflammatory cytokine

March 4, 1999

Placebo-controlled study supports the efficacy of Alrex in seasonal allergic conjunctivitis

March 1, 1999

Worldwide strategic alliance established by Agennix and Santen for lactoferrin

Feb. 26, 1999

Novel antioxidant/antiproliferative NSAID esters and amides designed by Alcon

Feb. 19, 1999

CoCensys enters research agreements with Senju and Parke-Davis

Feb. 18, 1999

FDA says KeraVision's treatment for myopia approvable

Feb. 17, 1999

Patient enrollment completed in loteprednol/antibiotic combination study

Feb. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...